Robotic Assisted Laparoscopic Radical Prostatectomy: Perioperative Outcomes Of 1500 Consecutive RALPs
Main Category: Prostate / Prostate CancerAlso Included In: Urology / Nephrology; Men's health
Article Date: 23 Sep 2007 - 0:00 PDT
| Patient / Public: | ![]() |
5 (3 votes) |
| Healthcare Prof: | ![]() |
UroToday.com - Presented Wednesday, 05 September 2007 at the 29th Congress of the Societe International d'Urologie - SIU 2007 - Optimizing Clinical Outcomes in Prostate and Renal Cell Carcinomas - The Second Annual Symposium on Advanced GU Malignancy - Palais des Congres de Paris, France
Introduction: There has been an increasing demand for the use of robotic assisted laparoscopic radical prostatectomy (RALP) in the last 5 years for the treatment of prostate cancer. We report the perioperative outcomes of 1500 consecutive RALPs performed by a single surgeon (VRP) over a 53 month period.
Methods: Using a six port, transperitoneal approach, 1500 consecutive patients underwent RALP. Data recollected included quality of life questionnaires (EPIC, SHIM, AUA), age, height, weight, body mass index (BMI); prostate specific antigen (PSA), clinical stage and Gleason grade. Perioperative outcome measures included: operative time (OR), estimated blood loss (EBL), prostate size, length of hospital stay, pathology and time of catheter removal.
Results: Mean OR was 105 minutes and EBL was 111ml with no transfusions or mortalities. Ninety seven percent of patients were discharged on postoperative day, one with a mean catheter time of 6.3 days (range 4 28). Positive margin rate was 4% for T2 tumors, 34% for T3, 40% for T4 tumors and an overall of 11.6% for the entire series.
Conclusions: RALP is a safe and feasible procedure for the treatment of prostate cancer.
Authors: Palmer KJ, Shah K, Thaly R, Patel V
UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.
To access the latest urology news releases from UroToday, go to: www.urotoday.com
----------------------------
Copyright © 2007 - UroToday
Reproduced for Medical News Today with permission of UroToday.
----------------------------
Visit our prostate / prostate cancer section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/83331.php>
APA
http://www.medicalnewstoday.com/releases/83331.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




